# A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy

> **NCT00283504** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of The King's Daughters** · enrollment: 13 (actual)

## Conditions studied

- ALLERGIC ASTHMA

## Interventions

- **DRUG:** ANTI-IGE THERAPY (XOLAIR)

## Key facts

- **NCT ID:** NCT00283504
- **Lead sponsor:** Children's Hospital of The King's Daughters
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-02-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283504, "A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00283504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*